Unsuccessful Desensitization to Paclitaxel in a Patient With High Basophil Sensitivity

J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):263-265. doi: 10.18176/jiaci.0590. Epub 2020 Jul 30.

Authors

P Kopač^{1

2}, A Koren¹, M Jošt¹, D Mangaroski³, M Lainščak⁴, P Korošec¹

Affiliations

¹ University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
² Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
³ Institute of Oncology, Ljubljana, Slovenia.
⁴ Division of Cardiology, General Hospital Murska Sobota, Murska Sobota, Slovenia.

PMID: 32732178
DOI: 10.18176/jiaci.0590

No abstract available

Keywords: Basophil activation test; Desensitization; Paclitaxel hypersensitivity.

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Basophil Degranulation Test
Basophils / pathology*
Breast Neoplasms / drug therapy*
Desensitization, Immunologic / methods*
Drug Hypersensitivity / therapy*
Drug-Related Side Effects and Adverse Reactions / therapy*
Female
Humans
Middle Aged
Paclitaxel / adverse effects
Paclitaxel / therapeutic use*
Treatment Failure

Substances

Antineoplastic Agents
Paclitaxel